Frode Marc Bohan was re-elected as Chairman of the Board of Directors for NattoPharma ASA at the company’s Annual General Meeting, held Friday 20th May, 2016. Frode Marc Bohan is re-elected for a period of two years, up until the ordinary Annual General Meeting in 2018. The Annual General Meeting further resolved to increase the Board of Directors from 3 to 5 members. Stefan Halldén and Annette Emlqvist were elected for a two -year period, until the ordinary Annual General Meeting in 2018. Stefan Halldén (50) is today working chairman of Life Science Sweden AB, a long time shareholder in NattoPharma and a valuable contributor to the development of the company. The last year he also held the position as a member of the Election Committee. Halldén has a long track record from international finance. Anette Elmqvist (67) has an extensive operational experience from various health and pharma companies as Swedish Pharmacies, KabiVitrum AB, Pharmacia Biopharmaceuticals AB, Pharmacia & Upjohn AB, Active Biotech AB, PowderJect SBL Vaccin AB, SBL Vaccin AB and Unitech Biopharma AB. Today Elmqvist serve as VP Quality Assurance in Scandinavian Biopharma AB. “The election of Stefan Halldén and Annette Elmqvist as members of the Board of Directors in NattoPharma ASA is continuing the efforts to move NattoPharma from an “entrepreneurial start-up company” within the dietary supplement business segment to a visible player within global biotechnology, nutraceutical and the pharmaceutical field. Annette Elmqvist extensive operational and pharmaceutical production experience will be a great asset for NattoPharma. Combined with Stefan Halldén extensive financial background, I believe that the extended board will contribute greatly to the success of NattoPharma ASA” says Frode M. Bohan, Chairman of the Board in NattoPharma For more information, please contact: Kjetil Ramsøy CFO, NattoPharma E-mail: kjetil.ramsoy@nattopharma.com This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. About NattoPharma and MenaQ7® NattoPharma ASA, based in Norway, is the world's leader in vitamin K2 R&D. NattoPharma is the exclusive international supplier of MenaQ7® Vitamin K2 as MK -7, the best documented, commercially available Vitamin K2 as MK-7 with guaranteed actives and stability, clinical substantiation, and international patents granted and pending. The company has a multi-year research and development program to substantiate and discover the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements. With a global presence, the company established its North American subsidiary, NattoPharma USA, Inc., in Metuchen, NJ. For more information, visit www.nattopharma.com or www.Menaq7.com
NATTOPHARMA: RE-ELECTION OF CHAIRMAN, AND ELECTION OF TWO
Top 10 Most Recent News Articles
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China
Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...
Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull
Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...
Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026
Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...
Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
FFR's Michigan Milestone and Major Robotics Update
Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...
Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026
A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue ReadingTop 5 Most Recently Viewed Articles
Daniel Pink on Leadership and Workplace Evolution Insights
Exploring Leadership in a Changing Workplace The recent episode of Info-Tech Research Group's podcast, Digital Disruption, highlights a thought-provoking discussion with bestselling author Daniel Pink, focusing on how leaders can adapt in a time he describes as 'the great sort'. This term encapsulates the ongoing transformation in our approach to work, leadership, and the...
Continue Reading
MORSE Corp's Community Cleanup Initiative: Making an Impact
MORSE Corp's Commitment to Community Service MORSE Corp recently dedicated an entire day to community service by hosting a cleanup initiative at local beaches and parks. On a beautiful Wednesday, the organization mobilized its team to gather at a coastal spot to improve the environment and promote community spirit. This initiative is part of their annual effort to...
Continue Reading
FDA's New Proposal to Enhance Nutrition Awareness on Food Labels
Revolutionizing Nutrition Transparency for Consumers Today, the U.S. Food and Drug Administration (FDA) is taking significant steps towards improving consumer awareness about the nutritional value of packaged foods. A new proposal dictates that most packaged foods will require a prominent front-of-package (FOP) nutrition label. This initiative is part of a broader...
Continue Reading
CW Bancorp Declares Quarterly Dividend for Shareholders
CW Bancorp Announces Dividend Declaration CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, has approved a quarterly cash dividend. The news comes as the company continues to prioritize shareholder value while supporting its growth journey. Details of the Cash Dividend The Board of Directors of CW Bancorp declared a cash dividend of $0.23 per common...
Continue Reading
Universal Electronics Unveils QuickSet homeSense at CES Event
Universal Electronics Introduces QuickSet homeSense Technology Universal Electronics Inc. (NASDAQ: UEIC) has made headlines by launching its innovative QuickSet homeSense technology. This introduction took place at the prestigious International Consumer Electronics Show (CES) where the spotlight is often on groundbreaking tech. UEI, a leader in wireless control solutions,...
Continue Reading